Is it better to remove pharmaceuticals in decentralized or conventional wastewater treatment plants? A life cycle assessment comparison.

After ingestion, pharmaceuticals are excreted unchanged or metabolized. They subsequently arrive in conventional wastewater treatment plants and are then released into the environment, often without undergoing any degradation. Conventional treatment plants can be upgraded with post treatment, alternatively the removal of pharmaceuticals could be achieved directly at point sources. In the European project PILLS, several solutions for decentralized treatment of pharmaceuticals at hospitals were investigated at both pilot plant and full scale, and were then compared to conventional and upgraded centralized treatment plants using Life Cycle Assessment (LCA). Within the scope of the study, pharmaceuticals were found to have a comparatively minor environmental impact. As a consequence, an additional post treatment does not provide significant benefits. In the comparison of post treatment technologies, ozonation and activated carbon performed better than UV. These results suffer however from high uncertainties due to the assessment models of the toxicity of pharmaceuticals in LCA. Our results should therefore be interpreted with caution. LCA is a holistic approach and does not cover effects or issues on a local level, which may be highly relevant. We should therefore apply the precautionary ALARA principle (As Low As Reasonably Achievable) and not conclude that the effect of pharmaceuticals is negligible in the environment.

[1]  M. Huijbregts,et al.  Normalisation in product life cycle assessment: an LCA of the global and European economic systems in the year 2000. , 2008, The Science of the total environment.

[2]  T. Tuhkanen,et al.  Elimination of pharmaceuticals in sewage treatment plants in Finland. , 2007, Water research.

[3]  Werner Kratz.  Ecotoxicological Risk of Human Pharmaceuticals in Brandenburg Surface Waters , 2008 .

[4]  N Kreuzinger,et al.  Carbamazepine as a possible anthropogenic marker in the aquatic environment: investigations on the behaviour of Carbamazepine in wastewater treatment and during groundwater infiltration. , 2004, Water research.

[5]  B. Chefetz,et al.  Sorption and mobility of pharmaceutical compounds in soil irrigated with reclaimed wastewater. , 2008, Chemosphere.

[6]  Hans-Jürgen Dr. Klüppel,et al.  The Revision of ISO Standards 14040-3 - ISO 14040: Environmental management – Life cycle assessment – Principles and framework - ISO 14044: Environmental management – Life cycle assessment – Requirements and guidelines , 2005 .

[7]  Adriano Joss,et al.  Occurrence and sorption behavior of sulfonamides, macrolides, and trimethoprim in activated sludge treatment. , 2005, Environmental science & technology.

[8]  H. Larsen,et al.  Deliverable 4.3 Decision support guideline based on LCA and cost/efficiency assessment , 2010 .

[9]  J. Choubert,et al.  Fate of pharmaceuticals and personal care products in wastewater treatment plants--conception of a database and first results. , 2009, Environmental pollution.

[10]  J Vollertsen,et al.  The sewer as a bioreactor--a dry weather approach. , 2002, Water science and technology : a journal of the International Association on Water Pollution Research.

[11]  D. Barceló,et al.  Removal of pharmaceuticals during wastewater treatment and environmental risk assessment using hazard indexes. , 2010, Environment international.

[12]  D W Meals,et al.  Phosphorus reductions following riparian restoration in two agricultural watersheds in Vermont, USA. , 2002, Water science and technology : a journal of the International Association on Water Pollution Research.

[13]  Walter Giger,et al.  Occurrence and fate of antibiotics as trace contaminants in wastewaters, sewage sludges, and surface waters , 2003 .

[14]  Mark A. J. Huijbregts,et al.  USEtox—the UNEP-SETAC toxicity model: recommended characterisation factors for human toxicity and freshwater ecotoxicity in life cycle impact assessment , 2008 .

[15]  Albert Germain,et al.  Life Cycle Assessment of Water: From the pumping station to the wastewater treatment plant (9 pp) , 2007 .

[16]  G. Dóka.  Life Cycle Inventories of Waste Treatment Services , 2003 .

[17]  M. Carballa,et al.  Environmental assessment of anaerobically digested sludge reuse in agriculture: potential impacts of emerging micropollutants. , 2010, Water research.

[18]  E. Furlong,et al.  Presence and distribution of wastewater‐derived pharmaceuticals in soil irrigated with reclaimed water , 2006, Environmental toxicology and chemistry.

[19]  K. Fent,et al.  Ecotoxicology of human pharmaceuticals. , 2006, Aquatic toxicology.

[20]  M. Guerbet,et al.  Hospital wastewater genotoxicity. , 2006, The Annals of occupational hygiene.

[21]  Mark A J Huijbregts,et al.  Ranking potential impacts of priority and emerging pollutants in urban wastewater through life cycle impact assessment. , 2008, Chemosphere.

[22]  Stefanie Hellweg,et al.  Uncertainty Analysis in Life Cycle Assessment (LCA): Case Study on Plant-Protection Products and Implications for Decision Making (9 pp + 3 pp) , 2005 .

[23]  M Ahnert,et al.  Identification of overall degradation in sewer systems from long-term measurements and consequences for WWTP simulations. , 2005, Water science and technology : a journal of the International Association on Water Pollution Research.

[24]  Adriano Joss,et al.  Removal of pharmaceuticals and fragrances in biological wastewater treatment. , 2005, Water research.

[25]  Michael Zwicky Hauschild,et al.  Evaluation of Ecotoxicity Effect Indicators for Use in LCIA (10+4 pp) , 2007 .

[26]  Adriano Joss,et al.  A rapid method to measure the solid-water distribution coefficient (Kd) for pharmaceuticals and musk fragrances in sewage sludge. , 2004, Water research.

[27]  Karin Treyer,et al.  Environmental toxicology and risk assessment of pharmaceuticals from hospital wastewater. , 2011, Water research.

[28]  J. C. Durán-Alvarez,et al.  Accumulation and leaching potential of some pharmaceuticals and potential endocrine disruptors in soils irrigated with wastewater in the Tula Valley, Mexico. , 2010, Chemosphere.

[29]  Stig Irving Olsen,et al.  Normalization in EDIP97 and EDIP2003: updated European inventory for 2004 and guidance towards a consistent use in practice , 2011 .

[30]  H Kroiss,et al.  Removal of selected pharmaceuticals, fragrances and endocrine disrupting compounds in a membrane bioreactor and conventional wastewater treatment plants. , 2005, Water research.

[31]  Christian Braun,et al.  Ozonung von gereinigtem Abwasser: Schlussbericht Pilotversuch Regensdorf , 2009 .